ARCHIVES

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut

February 22, 1980